Sheldon Spector

643 total citations
21 papers, 495 citations indexed

About

Sheldon Spector is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Sheldon Spector has authored 21 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology and Allergy. Recurrent topics in Sheldon Spector's work include Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (7 papers). Sheldon Spector is often cited by papers focused on Asthma and respiratory diseases (13 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (7 papers). Sheldon Spector collaborates with scholars based in United States, Switzerland and Germany. Sheldon Spector's co-authors include Mary Beth Fasano, Isaac Melamed, Jordan S. Orange, John B. Hagan, Mikhail Rojavin, David M. Cocchetto, Richard L. Wasserman, O. Zenker, Howard M. Schanker and Christopher F. Nicodemus and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Otolaryngology.

In The Last Decade

Sheldon Spector

19 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheldon Spector United States 12 234 195 153 135 71 21 495
Angela Miniaci Italy 11 57 0.2× 34 0.2× 52 0.3× 62 0.5× 59 0.8× 22 346
Elizabeth Feuille United States 13 84 0.4× 48 0.2× 280 1.8× 118 0.9× 40 0.6× 27 469
Motoki Bonno Japan 10 95 0.4× 75 0.4× 40 0.3× 113 0.8× 44 0.6× 28 487
Nasrin Behniafard Iran 11 87 0.4× 43 0.2× 89 0.6× 149 1.1× 20 0.3× 41 334
Mary Grace Baker United States 14 94 0.4× 66 0.3× 267 1.7× 45 0.3× 4 0.1× 37 431
Achiya Amir Israel 13 49 0.2× 28 0.1× 17 0.1× 72 0.5× 53 0.7× 35 338
Dilek Doğruel Türkiye 12 54 0.2× 100 0.5× 70 0.5× 78 0.6× 30 0.4× 53 366
B Z Garty Israel 11 66 0.3× 60 0.3× 93 0.6× 89 0.7× 31 0.4× 20 436
Saskia Gruber Austria 12 82 0.4× 42 0.2× 118 0.8× 73 0.5× 13 0.2× 37 352
Maria Xatzipsalti Greece 9 362 1.5× 166 0.9× 255 1.7× 81 0.6× 3 0.0× 18 592

Countries citing papers authored by Sheldon Spector

Since Specialization
Citations

This map shows the geographic impact of Sheldon Spector's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Spector with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Spector more than expected).

Fields of papers citing papers by Sheldon Spector

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon Spector. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Spector. The network helps show where Sheldon Spector may publish in the future.

Co-authorship network of co-authors of Sheldon Spector

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon Spector. A scholar is included among the top collaborators of Sheldon Spector based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon Spector. Sheldon Spector is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erpenbeck, Veit J., Todor A. Popov, S. David Miller, et al.. (2015). QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study. PA2125–PA2125. 5 indexed citations
2.
Chipps, Bradley E., et al.. (2012). Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma. Allergy and Asthma Proceedings. 33(5). 377–385. 14 indexed citations
3.
Spector, Sheldon, et al.. (2011). Labile Blood Eosinophilia in Asthma. CHEST Journal. 140(4). 214A–214A.
4.
Hagan, John B., Mary Beth Fasano, Sheldon Spector, et al.. (2010). Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency. Journal of Clinical Immunology. 30(5). 734–745. 108 indexed citations
5.
Hagan, J.J., Sheldon Spector, Richard L. Wasserman, et al.. (2010). Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients with Primary Immunodeficiency. Journal of Allergy and Clinical Immunology. 125(2). AB140–AB140. 2 indexed citations
6.
Spector, Sheldon & Ricardo Tan. (2008). EFFECT OF OMALIZUMAB ON PATIENTS WITH CHRONIC URTICARIA: ISSUES WITH THE DETERMINATION OF AUTOIMMUNE URTICARIA. Annals of Allergy Asthma & Immunology. 100(1). 88–89.
7.
Corren, Jonathan, et al.. (2001). Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure. Annals of Allergy Asthma & Immunology. 87(3). 211–217. 20 indexed citations
8.
Spector, Sheldon. (1999). Foreword. Journal of Allergy and Clinical Immunology. 103(3). S377–S377. 6 indexed citations
9.
Spector, Sheldon. (1999). Ideal pharmacotherapy for allergic rhinitis. Journal of Allergy and Clinical Immunology. 103(3). S386–S387. 17 indexed citations
10.
Spector, Sheldon. (1996). Bronchial inhalation challenge procedures with allergens and other bronchoconstrictor substances.. PubMed. 28(4). 112, 115–8. 3 indexed citations
11.
Spector, Sheldon. (1995). The common cold: Current therapy and natural history. Journal of Allergy and Clinical Immunology. 95(5). 1133–1138. 32 indexed citations
12.
Spector, Sheldon, et al.. (1995). Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma. Journal of Allergy and Clinical Immunology. 96(2). 174–181. 61 indexed citations
13.
Spector, Sheldon. (1992). The role of allergy in sinusitis in adults. Journal of Allergy and Clinical Immunology. 90(3). 518–520. 41 indexed citations
14.
Cocchetto, David M., et al.. (1991). Paradoxical Bronchospasm After Use of Inhalation Aerosols: A Review of the Literature. Journal of Asthma. 28(1). 49–53. 41 indexed citations
15.
Spector, Sheldon. (1991). Asthma and chronic obstructive lung disease: A pharmacologic approach. Disease-a-Month. 37(1). 7–58. 1 indexed citations
16.
Margolskee, Dorothy J., Robert J. Dockhorn, E. Israel, et al.. (1991). 677 The therapeutic effects of MK-571, a potent and selective leukotriene (LT) D4 receptor antagonist, in patients with chronic asthma. Journal of Allergy and Clinical Immunology. 87(1). 309–309. 43 indexed citations
17.
Tinkelman, David G., James P. Kemp, Jerald W. Koepke, et al.. (1990). Evaluation of the Safety and Efficacy of Multiple Doses of Azelastine to Adult Patients with Bronchial Asthma over Time. American Review of Respiratory Disease. 141(3). 569–574. 19 indexed citations
18.
Spector, Sheldon. (1990). Blockage of a “nonspecific” provocational challenge as a model for predicting clinical efficacy. Journal of Allergy and Clinical Immunology. 86(4). 657–659. 2 indexed citations
19.
Spector, Sheldon. (1989). Ocular, Nasal and Oral Cromolyn Sodium in the Management of Non-Asthmatic Allergic Problems. Allergy and Asthma Proceedings. 10(3). 191–195. 2 indexed citations
20.
Spector, Sheldon, et al.. (1977). Evaluation of gastro-pulmonary aspiration by a radioactive technique: concise communication.. PubMed. 18(11). 1079–81. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Miniaci Breakdown of academic impact, for papers by Elizabeth Feuille Breakdown of academic impact, for papers by Motoki Bonno Breakdown of academic impact, for papers by Nasrin Behniafard Breakdown of academic impact, for papers by Mary Grace Baker Breakdown of academic impact, for papers by Achiya Amir Breakdown of academic impact, for papers by Dilek Doğruel Breakdown of academic impact, for papers by B Z Garty Breakdown of academic impact, for papers by Saskia Gruber Breakdown of academic impact, for papers by Maria Xatzipsalti
Rankless by CCL
2026